R Sitruk-Ware

In broad support of the findings of the Heart and Estrogen/progestin Replacement Study (HERS) and other trials, the recently published preliminary findings of the Women's Health Initiative (WHI) study buttress the view that hormone replacem…

THERAPEUTIC APPLICATIONS: Antiprogestins are a promising class of therapeutic agents in the field of reproductive health. Mifepristone (exRU486) remains the leading compound of this class and is the only one presently used in clinical pract…

Since the luteinizing hormone-releasing hormone (LH-RH) has been identified and its mode of action understood, it has become possible to envisage a therapeutic use of long-acting, non toxic analogues. Biochemical modifications of the decape…